Long-Term Care
Long-term care is a high-growth segment of the changing health care market. Recognizing and addressing cognitive and neurological issues that can arise with aging and impact mental health is essential for developing high-quality long-term care. Here you will find resources to keep you up to date on the latest in clinical practices, provider tools, and news.
Featured Resources
Class Is In Session – Pseudobulbar Affect (PBA) Fictional Patient Cases & The Physician’s Perspective – Classroom Session #5
-
Class Is In Session – Pseudobulbar Affect (PBA) Patient & Caregiver Burden Of PBA – Classroom Session #3
VideoNovember 10, 2023Pseudobulbar Affect (PBA): Patient & Caregiver Burden Of PBA -
Class Is In Session – Pseudobulbar Affect (PBA) Criteria & Etiology Of PBA – Classroom Session #1
VideoNovember 10, 2023Pseudobulbar Affect (PBA): Criteria & Etiology Of PBA -
Survey Of Long-Term Care Facilities Indicates 4.1% Increase In Nursing Pay In 2023
ArticleJuly 31, 2023From 2022 to 2023, nurses at assisted living, personal care, and residential care facilities received average wage increases of 4.1%….View Resource Library
Conversations Matter: Discussing The Impact of Care Partner Burden When Caring For Individuals Living With Agitation associated With Alzheimer’s Dementia (AAD)
-
Introduction To Pseudobulbar Affect (PBA)
InfographicNovember 27, 2023Pseudobulbar Affect (PBA) is a neurological condition that occurs secondary to a variety of otherwise unrelated neurological conditions and is… -
Class Is In Session – Pseudobulbar Affect (PBA) Fictional Patient Cases & The Physician’s Perspective – Classroom Session #5
VideoNovember 10, 2023Pseudobulbar Affect (PBA): Fictional Patient Cases & The Physician’s Perspective -
Class Is In Session – Pseudobulbar Affect (PBA) Screening Tools For PBA Symptoms – Classroom Session #4
VideoNovember 10, 2023Pseudobulbar Affect (PBA): Screening Tools For PBA Symptoms
Advisors
-
Manju Beier, PharmD, BCGP, FASCP
Long-Term Care Section Advisor
Ask A Question About Agitation
Enter your question in the box below and click “Ask My Question” to submit your inquiry.
You must be logged in to ask a question in this section.
Disclaimer: The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Treatment-related questions will not be addressed. Users seeking medical advice should consult with their physician or other healthcare professional.
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) operates in a highly regulated and scrutinized industry. Therefore, we may not be able to address every questions or topic submitted. Topics which may not be addressed may include, but are not limited to questions related to: (1) specific medications, (2) branded items, (3) clinical or treatment advice relating to specific patient conditions. The lack of response to certain questions or comments should not be taken as an agreement with the view posed or an admission of any kind.
REQUEST A PRESENTATION
Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.
Top Requested Presentations
Agitation Associated With Alzheimer’s Dementia Disease State Education
The Importance Of Population Health: A Mental Health Perspective